Klimek, L.
Senti, G.
Hoffmann, H. J.
Kündig, T.
Article History
First Online: 15 September 2018
Compliance with ethical standards
:
: Dr. Kündig reports grants from AlleCure Corp. USA, grants from ImVision AG, during the conduct of the study. In addition, Dr. Kündig has patents on intralymphatic immunotherapy where he is named as inventor. These patents, however, are owned by the University of Zurich. Dr. Klimek reports grants and personal fees from ALK-Abelló, Denmark; personal fees from MEDA, Sweden; grants and personal fees from Novartis, Switzerland; grants and personal fees from Allergopharma, Germany; grants and personal fees from Bionorica, Germany; personal fees from Boehringer Ingelheim, Germany; grants and personal fees from GSK, Great Britain; grants and personal fees from Lofarma, Italy; grants from Biomay, Austria; grants from HAL, Netherlands; grants from LETI, Spain; grants from Roxall, Germany; and grants from Bencard, Great Britain, outside the submitted work. Dr. Senti declares that she has no conflict of interest. Dr. Hoffmann declares that he has no conflict of interest.
: This article does contain studies with human subjects performed by GS, TK and HJH.These studies have been performed according to the Declaration of Helsinki in its actual version and a positive vote of the responsible Ethical Committee was given before start of the study.